Submitted by Anonymous (not verified) on 16 July 2025 - 15:21
Human medicines European public assessment report (EPAR): Opuviz, aflibercept, Date of authorisation: 13/11/2024, Revision: 2, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Opuviz, aflibercept, Date of authorisation: 13/11/2024, Revision: 2, Status: Authorised